Gamida Cell Reports Second Quarter 2022 Financial Results and Provides Company Update
Gamida Cell Ltd. - Ordinary Shares (GMDA)
Last gamida cell ltd. - ordinary shares earnings: 11/13 04:01 pm
Check Earnings Report
Company Research
Source: Business Wire
- Received FDA acceptance of BLA for omidubicel with Priority Review; PDUFA target action date set for January 30, 2023 -- Dosed first patient in company-sponsored Phase 1/2 study of cryopreserved formulation of GDA-201 for the treatment of follicular and diffuse large B-cell lymphomas -- Finished second quarter of 2022 with $55.1 million in cash;sufficient funding for the company’s operations into mid-2023, excluding the cost of commercializing omidubicel -- Company to host conference call at 8:00 a.m. ET today - BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today provided a business update and reported financial results for the quarter ended June 30, 2022. Net loss for the second quarter of 2022 was $18.6 million, compared to a net loss of $23.6 million in the second quarter of 2021. As of June 30, 2022, Gamida Cell had total cash, ca
Show less
Read more
Impact Snapshot
Event Time:
GMDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMDA alerts
High impacting Gamida Cell Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
GMDA
News
- Gamida Cell to Report Fourth Quarter and Full-Year 2023 Financial ResultsGlobeNewswire
- GRO Biosciences Expands Executive Team with Appointment of Biopharma Veteran Tracey Lodie, PhD as Chief Development Officer [Yahoo! Finance]Yahoo! Finance
- Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR® [Yahoo! Finance]Yahoo! Finance
- Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®GlobeNewswire
GMDA
Earnings
- 11/14/23 - Beat
GMDA
Sec Filings
- 5/10/24 - Form 8-K/A
- 4/5/24 - Form 8-K/A
- 4/1/24 - Form SC
- GMDA's page on the SEC website